Patent directory · USPTO A61K / A61P
Patents matching “anti-”
1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11186625
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11185585
Methods and compositions for improving antiangiogenic therapy with anti-integrins
granted -
US 11186611
Peptide with anti-obesity and anti-diabetes activity and use thereof
granted -
US 11180540
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11180492
Anti-parasitic compounds and uses thereof
granted -
CA 3177888
ANTICORPS ANTI-HEMOJUVELINE (HJV) DE TRAITEMENT DE L'ANEMIE DE MALADIES CHRONIQUES
granted -
US 11174283
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11174316
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
granted -
US 11168144
Activatable anti-PDL1 antibodies, and methods of use thereof
granted -
US 11161876
Anti-inflammatory nanofibers
granted -
US 11161826
Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent
granted -
US 11155633
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof
granted -
US 11155621
Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof
granted -
US 11149025
Anti-cancer compounds
granted -
US 11141479
Stable anti-OSMR antibody formulation
granted -
US 11142578
Anti-MET antibodies, bispecific antigen binding molecules that bind MET, and methods of use thereof
granted -
US 11142530
Deep-sea fungus-derived anthraquinone compound and use thereof in preparing anti-allergic drugs
granted -
US 11124567
Anti-TREM2 antibodies and methods of use thereof
granted -
US 11124768
Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response
granted -
US 11117968
Activatable anti-CTLA-4 antibodies and uses thereof
granted -
US 11117975
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
granted -
US 11118180
Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)
granted -
US 11117955
Anti-Zika virus antibodies and methods of use
granted -
US 11111309
Method of reducing expression of DUX4 in a muscle cell by administering an anti-transferrin receptor antibody linked to an oligonucleotide targeting DUX4
granted